Drug Trial Radar · NCT06933472
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Last checked: Nov 19, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
264
Planned (sponsor's estimate)
Start
Jun 13, 2025
Primary completion
Jun 20, 2026
Study completion Jan 10, 2027
Sponsor
- Lead sponsor
- Alebund PharmaceuticalsIndustry
- Sponsor type
- Industry
- Collaborators
- Fortrea
- First posted
- Apr 18, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if AP301 could work in the patients receiving maintenance dialysis with elevated blood phosphate. The main questions it aims to answer are: * Does AP301 lower blood phosphate levels? * Does AP301 works on serum calcium level, calcium times phosphate level, and intact parathyroid hormone level? * What discomfort or medical problem do the patients have when taking AP301? * Does AP301 improve quality of life in Chinese patients? The researchers will compare AP301 to an ineffective comparator (a look-alike substance that contains low dose AP301) to see if AP301 works to treat elevated blood phosphate. In the study, the patients will experience the following stages in a chronicle order: * Stop all using blood phosphate-lowering drugs, * Take AP301 or the comparator three times a day for 8 weeks, * Take AP301 three times a day for 24 weeks, and * Take AP301 or the comparator three times a day for 3 weeks. In the first 32 weeks, the dose of AP301 will be adjusted upwards or downwards based on the patient's blood phosphate level and the study doctor's judgment. If the participant has a blood phosphate level above or below a certain level, they may receive additional treatment to lower the blood phosphate level.
Conditions
- Hyperphosphatemia
- Chronic Kidney Disease, Receiving Dialysis
- ESRD (End-Stage Renal Disease)
- Dialysis
Interventions
AP301Drug
Three times a day, administered orally with three meals at a daily dose level from 2.7g to 9.0g
AP301 Low DoseDrug
Three times a day, administered orally with three meals at a daily dose level from 0.075g to 0.25g
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in serum phosphate concentrations in the AP301 and the AP301 low dose groupsTime frame: From Baseline to the end of Week 8
Locations
42 sites in 2 countries. Site status is shown where the registry gives one.
Renal Consultants Medical Group
Granada Hills, California · Recruiting
North America Research Institute - San Dimas
San Dimas, California · Recruiting
North America Research Institute - San Dimas
San Dimas, California · Recruiting
Rocky Mountain Kidney Care - Lone Tree
Lone Tree, Colorado · Recruiting
PACT Kidney Care - Orange
Orange, Connecticut · Recruiting
US Renal Care - Fort Myers South
Fort Myers, Florida · Recruiting
Nephrology & Hypertension Specialists
Dalton, Georgia · Recruiting
Renal Associates Of Baton Rouge, LLC
Baton Rouge, Louisiana · Recruiting
Nephrology Associates, P.C. - Columbus
Columbus, Mississippi · Recruiting
Nephrology & Hypertension Associates Ltd - Tupelo
Tupelo, Mississippi · Recruiting
High Desert Nephrology Association - US Renal Care
Gallup, New Mexico · Recruiting
US Renal Care - West Cheektowaga
Cheektowaga, New York · Recruiting
NY Kidney & Hypertension Medicine
Ridgewood, New York · Recruiting
US Renal Care - Alexis
Toledo, Ohio · Recruiting
Dallas Renal Group - Dallas
Dallas, Texas · Recruiting
US Renal Care - Bluebonnet
Fort Worth, Texas · Recruiting
Gamma Medical Research
McAllen, Texas · Recruiting
US Renal Care - South San Antonio
San Antonio, Texas · Recruiting
US Renal Care - Hill Country
San Antonio, Texas · Recruiting
Peking University First Hospital
Beijing, Beijing Municipality, China · Recruiting
Beijing Tsinghua Chang Gung Hospital
Beijing, Beijing Municipality, China · Recruiting
Peking University International Hospital
Beijing, Beijing Municipality, China · Recruiting
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China · Recruiting
Henan Provincial People's Hospital
Zhengzhou, Henan, China · Recruiting
Zhengzhou University-First Affiliated Hospital
Zhengzhou, Henan, China · Recruiting
Huazhong University of Science and Technology-Tongji Medical College - Wuhan Union Hospital
Wuhan, Hubei, China · Recruiting
Wuhan University People's Hospital
Wuhan, Hubei, China · Recruiting
Central South University-The Third Xiangya Hospital
Changsha, Hunan, China · Recruiting
Southeast University-Zhongda Hospital
Nanjing, Jiangsu, China · Recruiting
Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Nanjing, Jiangsu, China · Recruiting
Nantong University-Affiliated Hospital
Nantong, Jiangsu, China · Recruiting
Nanjing Medical University-Wuxi People's Hospital (Wuxi No.1 People's Hospital)
Wuxi, Jiangsu, China · Recruiting
Subei People's Hospital
Yangzhou, Jiangsu, China · Recruiting
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China · Recruiting
Qingdao University-The Affiliated Hospital
Qingdao, Shandong, China · Recruiting
Yantai Yuhuangding Hospital
Yantai, Shandong, China · Recruiting
Shanghai Jiao Tong University School of Medicine (SJTUSM)-Renji Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Fudan University-Zhongshan Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Fudan University-Huashan Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China · Not yet recruiting
Showing 40 of 42 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.